Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Chapman

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
British Journal of Clinical Pharmacology|July 5, 2012
Online learning applied to a course on rational therapeutics: an international comparison between final year students of two medical schoolsRobert Likic, Casey White, Sandro Cinti, et al.
The American Journal of Cardiology|December 24, 2021
Meta-Analysis Comparing Apixaban Versus Rivaroxaban for Management of Patients With Nonvalvular Atrial FibrillationMamas A Mamas, Sarah Batson, Kevin G Pollock, et al.
Interventional Cardiology (London, England)|July 3, 2023
An Update on Anti-thrombotic Therapy Following Transcatheter Aortic Valve Implantation: Expert Cardiologist Opinion from a UK and Ireland Delphi GroupAzfar Zaman, Bernard Prendergast, David Hildick-Smith, et al.
Chembiochem : a European Journal of Chemical Biology|April 29, 2014
N-terminal modification of VEGF-A C terminus-derived peptides delineates structural features involved in neuropilin-1 binding and functional activityHaiyan Jia, Rehan Aqil, Lili Cheng, et al.
Current Medical Research and Opinion|January 11, 2023
A consensus viewpoint on the role of direct factor Xa inhibitors in the management of cancer-associated venous thromboembolism in the UKAlexander T Cohen, Gary Benson, Charlotte A Bradbury, et al.
Journal of Medicinal Chemistry|February 16, 2010
Small molecule inhibitors of the neuropilin-1 vascular endothelial growth factor A (VEGF-A) interactionAshley Jarvis, Charles K Allerston, Haiyan Jia, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
British Journal of Clinical Pharmacology|July 5, 2012
Online learning applied to a course on rational therapeutics: an international comparison between final year students of two medical schoolsRobert Likic, Casey White, Sandro Cinti, et al.
The American Journal of Cardiology|December 24, 2021
Meta-Analysis Comparing Apixaban Versus Rivaroxaban for Management of Patients With Nonvalvular Atrial FibrillationMamas A Mamas, Sarah Batson, Kevin G Pollock, et al.
Interventional Cardiology (London, England)|July 3, 2023
An Update on Anti-thrombotic Therapy Following Transcatheter Aortic Valve Implantation: Expert Cardiologist Opinion from a UK and Ireland Delphi GroupAzfar Zaman, Bernard Prendergast, David Hildick-Smith, et al.
Chembiochem : a European Journal of Chemical Biology|April 29, 2014
N-terminal modification of VEGF-A C terminus-derived peptides delineates structural features involved in neuropilin-1 binding and functional activityHaiyan Jia, Rehan Aqil, Lili Cheng, et al.
Current Medical Research and Opinion|January 11, 2023
A consensus viewpoint on the role of direct factor Xa inhibitors in the management of cancer-associated venous thromboembolism in the UKAlexander T Cohen, Gary Benson, Charlotte A Bradbury, et al.
Journal of Medicinal Chemistry|February 16, 2010
Small molecule inhibitors of the neuropilin-1 vascular endothelial growth factor A (VEGF-A) interactionAshley Jarvis, Charles K Allerston, Haiyan Jia, et al.
Pageof 3